A new generation of blood tests is making it easier for doctors to look for biological signs of Alzheimer’s disease, ...

PrecivityAD2 is cleared for adults ≥40 with cognitive impairment symptoms and is intended to complement, not replace, standard diagnostic evaluation incorporating history, exam, cognitive testing, ...

It is the first test the FDA has cleared for use in symptomatic adults aged 40 and over, according to C2N Diagnostics.

The new test promises to be “minimally invasive” and can help doctors identify symptoms of Alzheimer’s disease earlier.

The Food and Drug Administration has approved a new blood test to help identify signs of Alzheimer’s disease for people 55 and older who are already showing signs of cognitive decline. The test, from ...

Instead, focus on addressing potentially preventable brain risks. One large study found people who reached middle age without ...

The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help ​identify signs of Alzheimer’s disease in people age ‌55 and older with cognitive decline.

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...

Exclusive: Alzheimer’s blood tests should not be used on their own and risk leading people to believe they are inevitably going to develop dementia ...

Australians have seen a flurry of headlines announcing the arrival of blood tests for Alzheimer's disease. The news follows the Therapeutic Goods Administration's approval of new blood tests for ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

Will getting a blood test for amyloid levels eventually form part of routine primary care health checks, or are we putting ...